MCI-186 in open label phase

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Amyotrophic Lateral Sclerosis (ALS)

Drug Information

Target Indication

Amyotrophic Lateral Sclerosis (ALS)

Clinical Trial

Last updated: 7/21/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

SGIOY

Shionogi

Related Pipeline

Atrophy

Cerebral Palsy

Atrophy

Atrophy

Healthcare-associated Pneumonia (HCAP)

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts